Abstract
Abstractα-amylase and α-glucosidase are key enzymes implicated in carbohydrate digestion and their inhibition has been suggested as a powerful approach for regulating blood glucose levels. The present work describes for the first time their inhibition by a group of twelve hydroxylated 2-styrylchromones (2-SC). Our findings revealed that 2-SC display strong systematic inhibition of α-glucosidase rather than α-amylase activity. The number and position of the hydroxy groups in the chromone moiety further modulate the inhibitory profile of the studied compounds, and the derivatives bearing one catechol unit are efficient inhibitors of both enzymes. Enzyme kinetic studies indicate that all active compounds act as competitive inhibitors of α-amylase while most of them behave as non-competitive inhibitors of α-glucosidase. The results are promising and pave the way to further deciphering the potential of this class of compounds as a suitable alternative for the management of type 2 diabetes and its complications.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. International Diabetes Federation. IDF Diabetes Atlas, 90th Edition 2021. Available from: http://www.diabetesatlas.org/ Accessed 10 Sept 2023.
2. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–51.
3. Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab 2015;6:541.
4. Piero MN, Nzaro GM, Njagi JM. Diabetes mellitus – a devastating metabolic disorder. Asian J Biomed Pharm Sci 2014;40:1–7.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–90.